← Back to Screener
10x Genomics, Inc. Class A Common Stock (TXG)
Price$26.08
Favorite Metrics
Price vs S&P 500 (26W)118.63%
Price vs S&P 500 (4W)32.32%
Market Capitalization$3.33B
All Metrics
P/CF (Annual)24.49x
Book Value / Share (Quarterly)$6.24
P/TBV (Annual)2.81x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)7.57%
Cash Flow / Share (Quarterly)$1.02
Price vs S&P 500 (YTD)55.76%
Gross Margin (TTM)69.13%
Net Profit Margin (TTM)-6.77%
EPS (TTM)$-0.35
10-Day Avg Trading Volume2.34M
EPS Excl Extra (TTM)$-0.35
Revenue Growth (5Y)16.56%
EPS (Annual)$-0.35
ROI (Annual)-5.47%
Gross Margin (Annual)69.13%
Net Profit Margin (5Y Avg)-24.38%
Cash / Share (Quarterly)$4.10
Revenue Growth QoQ (YoY)0.61%
ROA (Last FY)-4.18%
Revenue Growth TTM (YoY)5.25%
EBITD / Share (TTM)$-0.19
ROE (5Y Avg)-18.67%
Operating Margin (TTM)-9.49%
Cash Flow / Share (Annual)$1.02
P/B Ratio4.18x
P/B Ratio (Quarterly)2.59x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)4.45x
Net Interest Coverage (TTM)-75.71x
ROA (TTM)-4.41%
EPS Incl Extra (Annual)$-0.35
Current Ratio (Annual)4.46x
Quick Ratio (Quarterly)3.95x
3-Month Avg Trading Volume2.44M
52-Week Price Return224.78%
EV / Free Cash Flow (Annual)21.96x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$5.75
P/S Ratio (Annual)5.18x
Asset Turnover (Annual)0.62x
52-Week High$26.45
Operating Margin (5Y Avg)-25.48%
EPS Excl Extra (Annual)$-0.35
CapEx CAGR (5Y)-31.16%
Tangible BV CAGR (5Y)0.48%
26-Week Price Return127.38%
Quick Ratio (Annual)3.95x
13-Week Price Return24.67%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.46x
Enterprise Value$2,857.813
Revenue / Share Growth (5Y)11.78%
Asset Turnover (TTM)0.65x
Book Value / Share Growth (5Y)-1.75%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)2.85x
Pretax Margin (Annual)-6.21%
Cash / Share (Annual)$4.10
3-Month Return Std Dev65.98%
Gross Margin (5Y Avg)72.95%
Net Income / Employee (TTM)$-0
ROE (Last FY)-5.47%
Net Interest Coverage (Annual)-66.13x
EPS Basic Excl Extra (Annual)$-0.35
P/FCF (TTM)25.61x
Receivables Turnover (TTM)9.53x
EV / Free Cash Flow (TTM)21.96x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.35
Receivables Turnover (Annual)9.53x
ROI (TTM)-5.69%
P/S Ratio (TTM)5.18x
Pretax Margin (5Y Avg)-23.57%
Revenue / Share (Annual)$5.15
Tangible BV / Share (Annual)$5.75
Price vs S&P 500 (52W)189.69%
Year-to-Date Return59.90%
5-Day Price Return10.60%
EPS Normalized (Annual)$-0.35
ROA (5Y Avg)-14.47%
Net Profit Margin (Annual)-6.77%
Month-to-Date Return22.84%
Cash Flow / Share (TTM)$-1.64
EBITD / Share (Annual)$-0.21
Operating Margin (Annual)-9.49%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)24.49x
ROI (5Y Avg)-18.67%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.35
P/TBV (Quarterly)2.81x
P/B Ratio (Annual)2.59x
Inventory Turnover (TTM)2.85x
Pretax Margin (TTM)-6.21%
Book Value / Share (Annual)$6.24
Price vs S&P 500 (13W)21.80%
Beta2.23x
P/FCF (Annual)25.61x
Revenue / Share (TTM)$5.06
ROE (TTM)-5.69%
52-Week Low$7.25
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.55
3.48
3.55
3.64
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
TXG10x Genomics, Inc. Class A Common Stock | 5.18x | 16.56% | 69.13% | -9.49% | $26.08 |
AAgilent Technologies Inc. | 4.87x | 5.41% | 52.60% | 20.40% | $121.87 |
WATWaters Corp | 10.11x | 6.00% | 59.28% | 25.36% | $327.77 |
MTDMettler-Toledo International | 6.77x | 5.47% | 59.37% | 26.05% | $1340.58 |
ILMNIllumina Inc | 4.74x | 6.04% | 66.61% | 18.44% | $134.50 |
RVTYRevvity, Inc. | 3.68x | -5.46% | 54.77% | 12.49% | $93.96 |
BIOBio-Rad Laboratories, Inc.Class A | 3.12x | 0.29% | 52.01% | 1.59% | $299.02 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.12x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRBruker Corporation | 1.80x | 11.57% | 47.13% | 1.40% | $40.70 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.80x | 11.57% | 47.13% | 1.40% | $318.56 |
AVTRAvantor, Inc. | 0.88x | 0.49% | 32.65% | -3.83% | $8.52 |
About
10x Genomics develops microfluidic-based instruments, consumables, and software for analyzing biological systems at high resolution and scale. The company's product portfolio includes the Chromium platform, Visium, and Xenium solutions, serving researchers and diagnostics customers globally across North America, Europe, Asia-Pacific, and China.